Literature DB >> 26978231

[Histological hanges in the placenta and vascularization of its villi in early- and late-onset preeclampsia].

A I Shchegolev1, V M Lyapin1, U N Tumanova2, D N Vodneva2, R G Shmakov2.   

Abstract

AIM: to make a comparative histological study of the placenta and a morphometric analysis of its terminal villi in early- and late-onset preeclampsia.
MATERIAL AND METHODS: Placentae from patients whose pregnancy had been complicated by the development of early- (n=26) or late-onset (n=84) preeclampsia were examined. A control group comprised placentae from 28 patients with physiological pregnancy and no extragenital diseases. The authors made a comparative histological study of placental tissue and a morphometric analysis of the terminal villi using the sections immunohistochemically stained for CD31.
RESULTS: It was determined that there was a preponderance of branching angiogenesis in the preeclamptic chorionic villi and an increase in the number of syncytial nodules and microcysts in the septae in late-onset preeclampsia. Morphometric analysis of immunohistochemical placental specimens established a reduction in the sizes and vascularization indicators of terminal villi that determine the development of placental hypoxia and are more pronounced in cases of early-onset preeclampsia.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26978231     DOI: 10.17116/patol201678113-18

Source DB:  PubMed          Journal:  Arkh Patol        ISSN: 0004-1955


  2 in total

1.  Optimisation and validation of immunohistochemistry protocols for cancer research.

Authors:  Peter Ella-Tongwiis; Alexander Makanga; Iqbal Shergill; Stephen Fôn Hughes
Journal:  Histol Histopathol       Date:  2021-02-22       Impact factor: 2.303

2.  The Number of Syncytial Knots and VEGF Expression in Placental Villi in Parturient Woman with COVID-19 Depends on the Disease Severity.

Authors:  A I Shchegolev; G V Kulikova; V M Lyapin; R G Shmakov; G T Sukhikh
Journal:  Bull Exp Biol Med       Date:  2021-07-22       Impact factor: 0.804

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.